今开:6.12 | 昨收:6.17 |
最高:6.25 | 最低:5.99 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.287793029E9 |
丰硕创投04-19 16:20
$Biocryst医药(BCRX)$ 2024年1月5日,BioCryst公司宣布用于治疗HAE的血浆激肽释放酶抑制剂ORLADEYO®(berotralstat)的2023年初步销售额为3.25亿美元,符合23Q3时给出的销售指引,并给出2024年销售指引为3.8-4亿美元。查看全文
Biocryst医药(BCRX)05-15 19:15
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015367 Size: 4 KB 网页链接查看全文
Biocryst医药(BCRX)05-08 04:15
$Biocryst医药(BCRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-021069 Act: 34 Size: 7 MB 网页链接查看全文
Biocryst医药(BCRX)05-22 19:35
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-016190 Size: 4 KB 网页链接查看全文
Biocryst医药(BCRX)06-15 04:35
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737 Size: 6 KB 网页链接查看全文
Biocryst医药(BCRX)04-26 04:35
$Biocryst医药(BCRX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022074 Act: 34 Size: 1 MB 网页链接查看全文
Biocryst医药(BCRX)04-26 04:25
$Biocryst医药(BCRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-018175 Act: 34 Size: 3 MB 网页链接查看全文
Biocryst医药(BCRX)05-15 19:15
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015363 Size: 4 KB 网页链接查看全文
Biocryst医药(BCRX)05-15 19:25
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015369 Size: 4 KB 网页链接查看全文
Biocryst医药(BCRX)06-14 04:25
$Biocryst医药(BCRX)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001171843-24-003430 Act: 34 Size: 372 KB 网页链接查看全文
chuminhua2020-04-12 13:09
4/9,美国北卡罗来纳州公司BioCryst Pharmaceuticals$Biocryst医药(BCRX)$ 宣布,该公司已经开始一项随机、双盲、安慰剂对照的研究入组,以评估galidesivir治疗COVID-19患者的安全性、临床影响和抗病毒作用。试验由NIAID资助。galidesivir是一种广谱抗病毒药物,在体外表现出对20多种RNA病毒的广谱...查看全文
崔一帆上海2020-03-08 00:41
$Biocryst医药(BCRX)$ $Co-diagnostics(CODX)$ $诺瓦瓦克斯医药(NVAX)$ 请问美股有类似华大基因的核酸检测的公司吗?查看全文
产业链观察2020-03-03 07:25
重磅| 又发现一个可能对#新冠肺炎# 有效的药物,同样基于Gottlieb的评论,我们还需要在$吉利德科学(GILD)$ 旁边尽快看看一个小分子药物,看看$Biocryst医药(BCRX)$ ,该公司具有remdesivir类似物galidesivir,对冠状病毒有活性,目前正在安全性试验中,结果即将发布。查看全文
智通财经APP获悉,2月2日(周二)美股盘前,WSB散户宣布“生物科技战”,受散户追捧的生物技术股票普涨。截至发稿,BioCryst制药(BCRX.US)涨10.57%,诺瓦瓦克斯医药 (NVAX.US)涨4.36%、德纳维制药(DVAX.US)涨10.03%、Inovio Pharmaceuti... 网页链接
Reddit大军向空头宣布“生物科技战”,若干被沽空生物科技股大幅上涨。Biocryst医药(BCRX)股价上涨逾40%,刷新2015年10月份以来盘中高位至11.98美元。 Reddit的WallStreetBets论坛上,有用户称该制药公司是“市场上被低... 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018846 Size: 5 KB 网页链接
$Biocryst医药(BCRX)$ 144 Report of proposed sale of securities Accession Number: 0001971857-24-000419 Act: 33 Size: 4 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018715 Size: 9 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018720 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018725 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018728 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018733 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018705 Size: 6 KB 网页链接
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018708 Size: 7 KB 网页链接